# Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

> **NCT03216408** · PHASE3 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 504 (actual)

## Conditions studied

- Glabellar Lines

## Interventions

- **DRUG:** Neuronox
- **DRUG:** Botox

## Key facts

- **NCT ID:** NCT03216408
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-30
- **Primary completion:** 2016-11-10
- **Final completion:** 2017-03-07
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216408, "Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03216408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*